Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Peripheral Artery Disease III: Interprofessional Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 16, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Pouya Entezami1, Devin N Holden2, Alan S Boulos1
1Department of Neurosurgery, Albany Medical Center, Albany, NY, USA.
Cangrelor, an intravenous P2Y12 inhibitor, shows promise for cerebrovascular stenting. Dose adjustments based on platelet function testing ensured safety and efficacy in neuroendovascular procedures.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: